Web Clinic - 20:00 - 21:30
Part 1: 24th Feb 2021 & Part 2: 10th March 2021
The i2i network is delighted to be re-launching our psoriasis programme as a stand alone programme in recognition of the fact that psoriasis needs to be managed a lot better in primary care with less inappropriate referrals into secondary care to reduce the pressure in the NHS. The role of the GP pharmacist is essential to help to ensure that patients receive annual reviews in relation to their psoriasis and that medicines are not just re-authorised without a thorough review.
This programme has been designed to equip you to competently manage psoriasis with an emphasis on doing so virtually.
This promotional psoriasis programme including educational resources, virtual workshops and implementation resources have been developed by Soar Beyond and LEO Pharma. The programme is fully funded by LEO Pharma and is intended for UK Healthcare Professionals only.
Date of preparation: January 2021
Dr Stephanie Gallard qualified as a pharmacist in 1991, a doctor in 1996, a GP in 2003, and after several years as a salaried GP moved into medical management in 2008. Following several deputy medical director roles, she decided in 2018 to return to the primary care front line as a “proper” GP again and renew her acquaintance with patients!
Dianne is an independent prescriber working as a senior clinical pharmacist within a GP practice and a mentor to other pharmacists within the PCN. Dianne also works as a dermatology pharmacist within a community based specialist dermatology service.
Dominika is a senior pharmacist and a pharmacy team lead at Fernbank Surgery in Lytham, Lancashire. She has extensive experience across community pharmacy, medicines management and primary care, including care homes. Her clinical interests are focused on the management of respiratory diseases, chronic pain and dermatological conditions.Read Bio
By attending this psoriasis web clinic part 1, you will have:
1. A better understanding of psoriasis and the impact on patient quality of life (QoL)
2. The opportunity for GP pharmacists to drive improved outcomes
3. A treatment and management overview including a holistic approach to care
4. Worked through a practical case study applying your learning
By attending this psoriasis web clinic part 2, you will have considered a change scenario which will equip you to:
1. Understand how to prioritise patients and implement effectively in practice
2. Understand how to run effective psoriasis reviews in general practice
3. How to optimise treatments and support patients holistically
4. Implement measurable improvements in patients and practice outcomes
This promotional psoriasis programme including educational resources, virtual workshops and implementation resources has been developed by Soar Beyond and LEO Pharma. The programme is fully funded by LEO Pharma and is intended for UK Healthcare Professionals only.
The intended audience is clinical pharmacists working in general practice wanting to set up and deliver a psoriasis review clinic. This training is to be used as a guide only and should be used to augment local guidelines and pathways. Pharmacists are encouraged to link with a GP prescribing / dermatology lead for supervision and mentorship to support clinical competence. Please note that the scope of the Soar Beyond i2i resources is for psoriasis only and it is not advisable that non-specialists manage other types of dermatological conditions.
Treatment options will be discussed as part of this programme. Treatment options will be discussed at the meeting, Enstillar® (calcipotriol/betamethasone diproprionate) and Dovobet® (calcipotriol/betamethasone diproprionate) Gel and Ointment Prescribing information and adverse reporting can be found here.
Reporting of Suspected Adverse Reactions
Adverse events should be reported.
Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Drug Safety at LEO Pharma by calling +44 (0)1844 347333 or e-mail: [email protected]
Click here to report an adverse event
Date of preparation – January 2021